Journal article
Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective
Abstract
Current guideline-based recommendations for oral dual-antiplatelet therapy in an acute coronary syndrome (ACS) include the use of newer adenosine diphosphate receptor inhibitor (ADPri) regimens and agents. The Canadian ACS Reflective Program is a multicenter observational quality-enhancement project that compared the use of ADPri therapy in 2 phases (November 2011-March 2013 and April 2013-November 2013) and also compared ADPri use with …
Authors
Gandhi S; Zile B; Tan MK; Saranu J; Bucci C; Yan AT; Robertson P; Quantz MA; Letovsky E; Tanguay J-F
Journal
Canadian Journal of Cardiology, Vol. 30, No. 12, pp. 1725–1731
Publisher
Elsevier
Publication Date
12 2014
DOI
10.1016/j.cjca.2014.09.011
ISSN
0828-282X